| Description | Urtoxazumab (TMA-15) is a humanized monoclonal antibody targeting Shiga toxin 2 (Stx2) [1]. |
| In vivo | Urtoxazumab (TMA-15) 在0.25-2.5 mg/kg的剂量范围内，通过单次注射，显著降低了B2F1感染小鼠的致死率，这一效果随时间和剂量增加而增强 [1]。 |
| Synonyms | HuVTm1.1, TMA-15 |
| molecular weight | N/A |
| CAS | 502496-16-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |